Related Tags >> FDA Rituxan Phase II Biogen Idec

Rheumatoid Arthritis News

Most Popular Rheumatoid Arthritis Story

Roche boasts new data supporting Actemra, MabThera

October 28, 2008 — 10:50am ET | By John Carroll

Roche announced that a fifth Phase III rheumatoid arthritis study confirmed disease remission in patients treated with Actemra. Investigators reported that the therapy can halt structural damage to... Read more...

Rheumatoid Arthritis Press Releases

New data shows ACTEMRA inhibits progression of joint destruction and improves physical function of patients with Rheumatoid Arth
Biogen Idec Announces Top-Line Results from Phase II Clinical Trial of Baminercept in Rheumatoid Arthritis
VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and T
Researchers discover how rheumatoid arthritis causes bone loss

Latest Headlines

AnaMar raises $9.6M for RA work
November 6, 2008
Roche boasts new data supporting Actemra, MabThera
October 28, 2008
FDA delays Roche's blockbuster Actemra
September 19, 2008
Rheumatology: fastest growing subject of trials
August 20, 2008
Pipex acquires mid-stage RA program
August 19, 2008
Trial set for rheumatoid arthritis cure
August 14, 2008
Blockbuster RA drug wins FDA panel vote
July 30, 2008
FDA staffers say Actemra works against RA
July 28, 2008
UCB files for Cimzia RA approval in Europe
July 1, 2008
Limerick raises $15M; Icahn offered $15B for Biogen; Neogen expands R&D
June 12, 2008
Itero raises $21M; Immunicon files for Chapter 11; AVI cuts staff;
June 11, 2008
SPOTLIGHT: Anesiva inks $114M licensing deal
June 5, 2008
Roche posts new data backing Actemra for RA
May 12, 2008
Rituxan fails (again) in late-stage lupus trial
April 29, 2008
Nuon gets $27M to fund a mid-stage trial
April 28, 2008
PBMs making big bucks off specialty drugs
April 22, 2008
GSK tests the miRNA waters with $600M deal
April 17, 2008
VC: Alimera land $30M in third round
March 20, 2008
Morphotek licenses anti-cancer antibody
March 6, 2008
TxCell rounds up $16M in second round
March 6, 2008

Paid Research Reports